PT141 – 10mg (10 vials)

Product Overview

PT-141, also known as bremelanotide, is a synthetic peptide associated with melanocortin receptor activity. It has been studied to better understand melanocortin signaling and its role in certain physiological processes.

Scientific Background

Bremelanotide has been investigated for its effects on melanocortin pathways. Research findings should not be interpreted as proof that an unverified product is safe or effective for a particular use. The regulatory status of products containing PT-141 depends on the formulation, intended use, and jurisdiction.

Product Specifications

• Product Name: PT-141 (Bremelanotide)
• Listed Strength: 10mg
• Package Format: 10 vials
• Compound Category: Synthetic peptide
• Research Area: Melanocortin receptor signaling

Product Information and Documentation

Before publishing this listing, verify the manufacturer’s label, stated strength, package quantity, storage requirements, batch identification, and available quality documentation. Confirm whether 10mg refers to each vial or the total amount across all 10 vials. Include purity or laboratory-testing claims only when supported by verifiable documentation.

Regulatory Disclaimer

Bremelanotide is an active pharmaceutical compound with specific approved uses in certain jurisdictions and formulations. Do not assume that a vial product is approved for those uses. Ensure that the product is lawfully marketed in the intended market and that all descriptions comply with applicable regulations. This description is informational only and is not medical advice.